Back to Insider Trading View Full Company Profile

JNJ

HEALTHY

JOHNSON & JOHNSON

CIK: 0000200406

Strong Sell (90% confidence)

Last activity: Feb 27, 2026

Financial Metrics

As of Dec 28, 2025 (10-K)

Revenue $56.08B
Total Cash $24.54B
Total Debt $10.63B
Debt/Equity 0.14
Current Ratio 1.04

Insider Roster (7 total, 7 active)

Insider Buys Sells Net Value Holdings
Duato Joaquin
CEO and Chairman of the Board
0 2 -$22.12M
79,634 shares
$17.60M
Wolk Joseph J
Exec VP, CFO
0 4 -$21.77M
38,961 shares
$9.46M
Swanson James D.
EVP, CIO
0 3 -$15.11M
25,698.131 shares
$6.24M
REED JOHN C
EVP, Innovative Medicine, R&D
0 3 -$13.11M
12,941 shares
$3.14M
Schmid Timothy
EVP, WW Chair, MedTech
0 3 -$5.85M
25,447 shares
$6.25M
Broadhurst Vanessa
EVP, Global Corp Affairs
0 1 -$1.51M
23,003 shares
$5.60M
Decker Robert J
VP Corporate Controller
0 1 -$1.01M
23,682 shares
$5.87M

Recent Transactions

SELL Decker Robert J (VP Corporate Controller)

4,075 shares @ $247.87

$1.01M

Feb 27, 2026

Conviction: | View SEC Filing →
SELL Schmid Timothy (EVP, WW Chair, MedTech)

1,322 shares @ $245.66

$325K

Feb 20, 2026

Conviction: | View SEC Filing →
SELL Schmid Timothy (EVP, WW Chair, MedTech)

13,625 shares @ $244.20

$3.33M

Feb 18, 2026

Conviction: | View SEC Filing →
SELL Schmid Timothy (EVP, WW Chair, MedTech)

8,998 shares @ $244.53

$2.20M

Feb 18, 2026

Conviction: | View SEC Filing →
SELL Wolk Joseph J (Exec VP, CFO)

33,386 shares @ $242.75

$8.10M

Feb 17, 2026

Conviction: | View SEC Filing →
SELL REED JOHN C (EVP, Innovative Medicine, R&D)

29,927 shares @ $243.00

$7.27M

Feb 17, 2026

Conviction: | View SEC Filing →
SELL Wolk Joseph J (Exec VP, CFO)

24,961 shares @ $242.68

$6.06M

Feb 17, 2026

Conviction: | View SEC Filing →
SELL REED JOHN C (EVP, Innovative Medicine, R&D)

21,721 shares @ $243.00

$5.28M

Feb 17, 2026

Conviction: | View SEC Filing →
SELL Swanson James D. (EVP, CIO)

20,521 shares @ $242.70

$4.98M

Feb 17, 2026

Conviction: | View SEC Filing →
SELL Wolk Joseph J (Exec VP, CFO)

19,241 shares @ $242.99

$4.68M

Feb 17, 2026

Conviction: | View SEC Filing →
SELL Wolk Joseph J (Exec VP, CFO)

12,066 shares @ $242.87

$2.93M

Feb 17, 2026

Conviction: | View SEC Filing →
SELL Broadhurst Vanessa (EVP, Global Corp Affairs)

6,197 shares @ $243.39

$1.51M

Feb 17, 2026

Conviction: | View SEC Filing →
SELL REED JOHN C (EVP, Innovative Medicine, R&D)

2,283 shares @ $243.00

$555K

Feb 17, 2026

Conviction: | View SEC Filing →
SELL Swanson James D. (EVP, CIO)

22,191 shares @ $243.71

$5.41M

Feb 13, 2026

Conviction: | View SEC Filing →
SELL Swanson James D. (EVP, CIO)

19,368 shares @ $243.76

$4.72M

Feb 13, 2026

Conviction: | View SEC Filing →
SELL Duato Joaquin (CEO and Chairman of the Board)

51,218 shares @ $220.99

$11.32M

Jan 26, 2026

Conviction: | View SEC Filing →
SELL Duato Joaquin (CEO and Chairman of the Board)

48,782 shares @ $221.48

$10.80M

Jan 26, 2026

Conviction: | View SEC Filing →

⚠️ Important Disclaimer

• This is AI-generated analysis for educational purposes only, not financial advice.

• Insider trading data is derived from SEC Form 4 filings and may contain errors.

• Always conduct your own research and consult qualified financial advisors before making investment decisions.